Cocaine-induced Dendritic Spine Formation in D1 and D2 Dopamine Receptor-containing Medium Spiny Neurons in Nucleus Accumbens

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2006 Feb 24

PMID 16492766

Citations 207

Authors

Ko-Woon Lee

Yong Kim

Amie M Kim

Kathryn Helmin

Angus C Nairn

Paul Greengard

Affiliations

Soon will be listed here.

Abstract

Psychostimulant-induced alteration of dendritic spines on dopaminoceptive neurons in nucleus accumbens (NAcc) has been hypothesized as an adaptive neuronal response that is linked to long-lasting addictive behaviors. NAcc is largely composed of two distinct subpopulations of medium-sized spiny neurons expressing high levels of either dopamine D1 or D2 receptors. In the present study, we analyzed dendritic spine density after chronic cocaine treatment in distinct D1 or D2 receptor-containing medium-sized spiny neurons in NAcc. These studies made use of transgenic mice that expressed EGFP under the control of either the D1 or D2 receptor promoter (Drd1-EGFP or Drd2-EGFP). After 28 days of cocaine treatment and 2 days of withdrawal, spine density increased in both Drd1-EGFP- and Drd2-EGFP-positive neurons. However, the increase in spine density was maintained only in Drd1-EGFP-positive neurons 30 days after drug withdrawal. Notably, increased DeltaFosB expression also was observed in Drd1-EGFP- and Drd2-EGFP-positive neurons after 2 days of drug withdrawal but only in Drd1-EGFP-positive neurons after 30 days of drug withdrawal. These results suggest that the increased spine density observed after chronic cocaine treatment is stable only in D1-receptor-containing neurons and that DeltaFosB expression is associated with the formation and/or the maintenance of dendritic spines in D1 as well as D2 receptor-containing neurons in NAcc.

Citing Articles

Early developmental changes in GABAA receptor expression in nucleus accumbens medium spiny neurons.

Wang Z, Folorunso O, Morris K, Berretta S, Engin E Front Neurosci. 2024; 18():1445162.

PMID: 39726828 PMC: 11669658. DOI: 10.3389/fnins.2024.1445162.

Cell type-specific epigenetic priming of gene expression in nucleus accumbens by cocaine.

Mews P, Van der Zee Y, Gurung A, Estill M, Futamura R, Kronman H Sci Adv. 2024; 10(40):eado3514.

PMID: 39365860 PMC: 11451531. DOI: 10.1126/sciadv.ado3514.

Changes in nucleus accumbens core translatome accompanying incubation of cocaine craving.

Kawa A, Hashimoto J, Beutler M, Guizzetti M, Wolf M bioRxiv. 2024; .

PMID: 39345421 PMC: 11429699. DOI: 10.1101/2024.09.15.613147.

Chronic Cocaine Use and Parkinson's Disease: An Interpretative Model.

Carbone M, Maremmani I Int J Environ Res Public Health. 2024; 21(8).

PMID: 39200714 PMC: 11354226. DOI: 10.3390/ijerph21081105.

Conditional knockout of Shank3 in the ventral CA1 by quantitative in vivo genome-editing impairs social memory in mice.

Chung M, Imanaka K, Huang Z, Watarai A, Wang M, Tao K Nat Commun. 2024; 15(1):4531.

PMID: 38866749 PMC: 11169449. DOI: 10.1038/s41467-024-48430-x.

References

Nikolic M, Chou M, Lu W, Mayer B, Tsai L . The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature. 1998; 395(6698):194-8. DOI: 10.1038/26034. View

Li Y, Acerbo M, Robinson T . The induction of behavioural sensitization is associated with cocaine-induced structural plasticity in the core (but not shell) of the nucleus accumbens. Eur J Neurosci. 2004; 20(6):1647-54. DOI: 10.1111/j.1460-9568.2004.03612.x. View

de Vries T, Cools A, Shippenberg T . Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization. Neuroreport. 1998; 9(8):1763-8. DOI: 10.1097/00001756-199806010-00017. View

Robinson T, Kolb B . Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci. 1999; 11(5):1598-604. DOI: 10.1046/j.1460-9568.1999.00576.x. View

Uslaner J, Badiani A, Norton C, Day H, Watson S, Akil H . Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur J Neurosci. 2001; 13(10):1977-83. DOI: 10.1046/j.0953-816x.2001.01574.x. View

Nye H, Hope B, Kelz M, Iadarola M, Nestler E . Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J Pharmacol Exp Ther. 1995; 275(3):1671-80. View

Smith Y, Bevan M, Shink E, Bolam J . Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience. 1999; 86(2):353-87. DOI: 10.1016/s0306-4522(98)00004-9. View

Woolverton W, Virus R . The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol Biochem Behav. 1989; 32(3):691-7. DOI: 10.1016/0091-3057(89)90019-1. View

Futter M, Uematsu K, Bullock S, Kim Y, Hemmings Jr H, Nishi A . Phosphorylation of spinophilin by ERK and cyclin-dependent PK 5 (Cdk5). Proc Natl Acad Sci U S A. 2005; 102(9):3489-94. PMC: 552943. DOI: 10.1073/pnas.0409802102. View

10.

Murase S, Mosser E, Schuman E . Depolarization drives beta-Catenin into neuronal spines promoting changes in synaptic structure and function. Neuron. 2002; 35(1):91-105. DOI: 10.1016/s0896-6273(02)00764-x. View

11.

Gerfen C, Keefe K, Gauda E . D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J Neurosci. 1995; 15(12):8167-76. PMC: 6577952. View

12.

Moratalla R, Elibol B, Vallejo M, Graybiel A . Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron. 1996; 17(1):147-56. DOI: 10.1016/s0896-6273(00)80288-3. View

13.

Zahm D . An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neurosci Biobehav Rev. 2000; 24(1):85-105. DOI: 10.1016/s0149-7634(99)00065-2. View

14.

Gerfen C, Engber T, Mahan L, Susel Z, Chase T, Monsma Jr F . D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990; 250(4986):1429-32. DOI: 10.1126/science.2147780. View

15.

Kalivas P . Glutamate systems in cocaine addiction. Curr Opin Pharmacol. 2004; 4(1):23-9. DOI: 10.1016/j.coph.2003.11.002. View

16.

Robinson T, Berridge K . Addiction. Annu Rev Psychol. 2002; 54:25-53. DOI: 10.1146/annurev.psych.54.101601.145237. View

17.

Pierce R, Kalivas P . A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev. 1997; 25(2):192-216. DOI: 10.1016/s0165-0173(97)00021-0. View

18.

Self D, Barnhart W, Lehman D, Nestler E . Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science. 1996; 271(5255):1586-9. DOI: 10.1126/science.271.5255.1586. View

19.

Badiani A, Oates M, Day H, Watson S, Akil H, Robinson T . Environmental modulation of amphetamine-induced c-fos expression in D1 versus D2 striatal neurons. Behav Brain Res. 1999; 103(2):203-9. DOI: 10.1016/s0166-4328(99)00041-8. View

20.

Caine S, Negus S, Mello N, Bergman J . Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J Pharmacol Exp Ther. 1999; 291(1):353-60. View